Manufacturer of highly validated primary antibodies and control antigens
Atlas Antibodies is the original manufacturer of highly validated primary antibodies and control antigens. The company was founded by researchers from the prestigious Human Protein Atlas project who wanted to make the unique antibodies developed in the project available to fellow researchers worldwide.
Atlas Antibodies manufactures and provides highly validated reagents that enable leading research in biology, pathology, and medicine for the purpose of understanding and improving human health. The primary antibodies portfolio covers different research areas:
Discover Atlas Antibodies’ products
Their standardized manufacturing process and the rigorous quality control ensure that the antibodies meet the highest level of specificity and selectivity required for your research to succeed.
Atlas Antibodies’ products are validated for use in IHC, WB and ICC-IF, according to the following protocols: Protocols for Antibody Applications
Enhanced validation is applied as an extra level of security in antibodies validation.
Bio-Connect Life Sciences supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.
Their extensive catalog of highly characterized antibodies and exclusive partnership with the Human Protein Atlas project provides them with a unique position to perform directed biomarker discovery research. They currently have several proprietary biomarkers available for licensing. Learn more about licensing.
New antibodies for exploring the glioma tumor microenvironment
Atlas Antibodies continuously updates its antibody portfolio with highly validated antibodies for use in glioma research. Discover the new antibodies here.
Publications with products by Atlas Antibodies
- Olpe C, Khamis D, Chukanova M, et al. A diffusion-like process accommodates new crypts during clonal expansion in human colonic epithelium. Gastroenterology. 2021;161(2):548-559.e23.
- He C, Xu K, Zhu X, et al. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nat Commun. 2021;12(1):4089.
- Schwabenland M, Salié H, Tanevski J, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594-1610.e11.
- Benito-Kwiecinski S, Giandomenico SL, Sutcliffe M, et al. An early cell shape transition drives evolutionary expansion of the human forebrain. Cell. 2021;184(8):2084-2102.e19.
- Teng S, Li YE, Yang M, et al. Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Res. 2020;30(1):34-49.
- Suh J, Romano DM, Nitschke L, et al. Loss of ataxin-1 potentiates alzheimer’s pathogenesis by elevating cerebral bace1 transcription. Cell. 2019;178(5):1159-1175.e17.
- Velasco S, Kedaigle AJ, Simmons SK, et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature. 2019;570(7762):523-527.
- Mathys H, Davila-Velderrain J, Peng Z, et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature. 2019;570(7761):332-337.
- Siles L, Ninfali C, Cortés M, Darling DS, Postigo A. ZEB1 protects skeletal muscle from damage and is required for its regeneration. Nat Commun. 2019;10(1):1364.
- Garcia-Bermudez J, Baudrier L, Bayraktar EC, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567(7746):118-122.